2 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Hyperphosphatemia: new trials by email Literature Review of Hyperphosphatemia trials Research Report on Hyperphosphatemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder Lanthanum Polystyrene Sulphonate Powder, Lanthanum Carbonate 500 MG, Placebo - Hyperphosphatemia | Phase 1 / Phase 2 | Unknown | Grand Life Science (Liaoning) Co., Ltd. | 48 | 2020-10-21 | 2021-07-28 |
| A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis VS-505 - End Stage Renal Disease, Hyperphosphatemia | Phase 1 / Phase 2 | Unknown | KDL Inc. | 30 | 2015-06-01 | 2016-02-08 |
Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Phosphorus Metabolism Disorders (2) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Grand Life Science (Liaoning) Co., Ltd. (1) · KDL Inc. (1)
Australia (1) · China (1)
Johan Rosman, MD, Ph.D (1) · Yanhua Ding, Ph.D (1)